Search

Search Constraints

You searched for: Author/Creator Sun, Jiangtao

Search Results

6. A phase I study of FCN-411, a pan-HER inhibitor, in EGFR-mutated advanced NSCLC after progression on EGFR tyrosine kinase inhibitors. (April 2022)